12.07 pm | 18 Dec 2007 |  Source: Moneycontrol.com

SSKI has maintained outperformer rating on Lupin with 15 month target price of Rs 800. We estimate 24% revenue CAGR and 25% profit CAGR (excluding li...

6.20 pm | 30 Nov 2007

Top Rankers 9th National Workshop on Nurturing Leadership for Business Excellence....

12.46 pm | 24 Oct 2007 |  Source: Moneycontrol.com

Lupin has declared its second quarter numbers. Its consolidated net profit has jumped by 46% to Rs 75.6 crore for the quarter ended September 2007 as ...

9.33 am | 12 Oct 2007

Sharekhan is bullish on Lupin and has maintained buy rating on the stock with target price of Rs 840....

12.52 pm | 10 Oct 2007

Kamal K Sharma, MD of Lupin informs that Kyowa buyout will not to be EPS accretive in near-term....

11.55 am | 04 Oct 2007

Enam is bullish on Lupin and has maintained outperformer rating on the stock with target price of Rs 765....

8.45 am | 28 Sep 2007

Lupin Ltd has acquired Rubamin Laboratories Ltd (RLL), part of the Baroda-based Rubamin group, for an undisclosed amount....

8.47 am | 13 Sep 2007

India’s Lupin has won its patent challenge against King Pharmaceuticals and Sanofi-Aventis for blood pressure drug Altace, which has sales of $700...

12.57 pm | 09 Aug 2007

Kamal K Sharma, MD, Lupin, said the all round growth led to higher growth in Q1. The company might take time for shelf space for Cefdinir due to autho...

11.37 am | 20 Jul 2007

Lupin has declared its first quarter results. The company's Q1 net profit was up at Rs 78.4 crore (Rs 784 million) versus Rs 50.7 crore (Rs 507 millio...

2.34 pm | 19 Jul 2007

Lupin has declared its first quarter results. The company's Q1 net profit was up at Rs 78.4 crore (Rs 784 million) versus Rs 50.7 crore (Rs 507 millio...

6.31 pm | 18 Jul 2007

Lupin will declare its Q1FY08 results. According to CNBC TV18 estimates, it net profit is seen up 48% at Rs 79.50 crore versus Rs 53.55 crore, YoY. It...

1.10 pm | 10 Jul 2007

Sharmila Joshi of Asit C Mehta is of the view that one can buy Dishman Pharma, Lupin....

1.47 pm | 19 Jun 2007

Lupin has reached an out-of-court settlement with Abbott Labs & Astellas, reports CNBC-TV18....

11.42 am | 06 Jun 2007

Anil Manghnani of Modern Shares & Stock Brokers is of the view that above Rs 730 there is more upside in Lupin....

10.35 am | 31 May 2007

Ashish Chaturmohta of Anand Rathi Securities and Sailav Qazi of Pinc Research give their F&O strategies for the day on SAIL and Lupin, respectively....

8.23 am | 15 May 2007

The agreement between drug-makers Lupin and GlaxoSmithKline (GSK), to market tuberculosis drugs in the Philippines, seems to have come unstuck. ...

11.38 am | 11 May 2007

Edelweiss Research is bullish on Lupin and has recommended buy rating on the stock. Broking house believes that the company is poised for an EPS CAGR ...

2.04 pm | 09 May 2007

Pharma major Lupin has booked intellectual properties revenue worth Rs 70 crore in FY07. Its domestic formulation segment growth was at 30% on a YoY a...

1.37 pm | 09 May 2007

Lupin has announced its fourth quarter results of FY07. The company has reported Q4 net profit of Rs 137.1 crore....